1. Home
  2. CUE vs VATE Comparison

CUE vs VATE Comparison

Compare CUE & VATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Cue Biopharma Inc.

CUE

Cue Biopharma Inc.

HOLD

Current Price

$0.49

Market Cap

49.6M

Sector

Health Care

ML Signal

HOLD

Logo INNOVATE Corp.

VATE

INNOVATE Corp.

HOLD

Current Price

$4.97

Market Cap

70.3M

Sector

Industrials

ML Signal

HOLD

Company Overview

Basic Information
Metric
CUE
VATE
Founded
2014
1994
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Metal Fabrications
Sector
Health Care
Industrials
Exchange
Nasdaq
Nasdaq
Market Cap
49.6M
70.3M
IPO Year
2018
1996

Fundamental Metrics

Financial Performance
Metric
CUE
VATE
Price
$0.49
$4.97
Analyst Decision
Strong Buy
Analyst Count
2
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
387.5K
14.1K
Earning Date
11-12-2025
11-12-2025
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$7,100,000.00
$1,099,900,000.00
Revenue This Year
$36.58
N/A
Revenue Next Year
$32.10
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.48
$4.05
52 Week High
$1.75
$13.79

Technical Indicators

Market Signals
Indicator
CUE
VATE
Relative Strength Index (RSI) 29.34 41.09
Support Level $0.47 $4.76
Resistance Level $0.66 $5.28
Average True Range (ATR) 0.05 0.20
MACD -0.00 -0.04
Stochastic Oscillator 13.05 7.69

Price Performance

Historical Comparison
CUE
VATE

About CUE Cue Biopharma Inc.

Cue Biopharma Inc is a clinical-stage biopharmaceutical company. It is developing a novel and proprietary class of biologics drugs for the selective modulation of the human immune system to treat a broad range of cancers and autoimmune disorders. Its objective is to provide patients suffering from cancer and autoimmune diseases with dramatically improved therapeutic outcomes through the platform of biologic drug product candidates. The other products under pipeline are CUE-101 as a Monotherapy, CUE-101 + Pembrolizumab, CUE-102, CUE-103, and others.

About VATE INNOVATE Corp.

Innovate Corp is a diversified holding company that has a portfolio of subsidiaries in a variety of operating segments which are; The infrastructure segment is comprised of DBM Global Inc, a fully integrated industrial construction, structural steel, and facility maintenance provider that provides fabrication and erection of structural steel and heavy steel plate services, The Life Sciences segment is comprised of Pansend Life Sciences which seeks to develop products to treat early osteoarthritis of the knee and aesthetic and medical technologies for the skin, and Spectrum segment is comprised of HC2 Broadcasting Holdings Inc which operates over-the-air broadcasting station across the United States.

Share on Social Networks: